UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000004146
Receipt No. R000004974
Official scientific title of the study The clinical effect of Silodosin for lower urinary tract symptoms after permanent prostate brachytherapy
Date of disclosure of the study information 2010/10/01
Last modified on 2016/09/13 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study The clinical effect of Silodosin for lower urinary tract symptoms after permanent prostate brachytherapy
Title of the study (Brief title) The effect of Silodosin for LUTS after permanent prostate brachytherapy
Region
Japan

Condition
Condition Prostate cancer
Classification by specialty
Urology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 The objective of this study is to evaluate the efficacy of silodosin for LUTS after prostate brachytherapy by comparing outcomes assessed by IPSS, QOL, OABSS, IIEF-5 scores. Patients are randomized into two group according to dosage of silodosin (4mg / day vs 8mg / day).
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Explanatory
Developmental phase Not applicable

Assessment
Primary outcomes IPSS score, QOL score, OABSS score, IIEF-5 score, SF-8 score, EPIC score, Uroflowmetry Qmax
Key secondary outcomes safety

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control Uncontrolled
Stratification NO
Dynamic allocation NO
Institution consideration Institution is not considered as adjustment factor.
Blocking NO
Concealment Numbered container method

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Silodocin 8mg/day
Interventions/Control_2 Silodocin 4mg/day
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male
Key inclusion criteria Pathologically proven prostate cancer.
Patient who underwent prostate brachytherapy or prostate brachyterapy in combination with external beam radiation therapy.
Written informed consent can be obtained.
Key exclusion criteria Patient with allergy against Silodocin.
Patient with neurogenic bladder, bladder neck constructure, urethral stenosis, vesical stone, or large bladder diverticulum.
Patient with active urinary tract infection.
Patient with severe renal dysfunction.
Patient with severe liver disease.
Patient who is considered to be inapropriate for this study by physisian.
Target sample size 60

Research contact person
Name of lead principal investigator Masato Fujisawa
Organization Kobe University Graduate School of Medicine
Division name Division of Urology
Address 7-5-2, Kusunoki-cho, Chuo-ku, Kobe, Japan
TEL 078-382-6155
Email

Public contact
Name of contact person Mototsugu Muramaki
Organization Kobe University Graduate School of Medicine
Division name Division of Urology
Address 7-5-2, Kusunoki-cho, Chuo-ku, Kobe, Japan
TEL 078-382-6155
Homepage URL
Email muramaki@med.kobe-u.ac.jp

Sponsor
Institute Kobe University Hospital
Institute
Department

Funding Source
Organization Kobe University Hospital
Organization
Division
Category of Funding Organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 神戸大学病院

Other administrative information
Date of disclosure of the study information
2010 Year 10 Month 01 Day

Progress
Recruitment status Preinitiation
Date of protocol fixation
2010 Year 09 Month 06 Day
Anticipated trial start date
2010 Year 10 Month 01 Day
Last follow-up date
2014 Year 10 Month 01 Day
Date of closure to data entry
2014 Year 12 Month 01 Day
Date trial data considered complete
2014 Year 12 Month 01 Day
Date analysis concluded
2015 Year 03 Month 01 Day

Related information
URL releasing protocol
Publication of results Partially published
URL releasing results
Results
Other related information

Management information
Registered date
2010 Year 09 Month 02 Day
Last modified on
2016 Year 09 Month 13 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000004974